Mesenchymal Stem Cell: Does it Work in an Experimental Model with Acute Respiratory Distress Syndrome?

Stem Cell Reviews and Reports

Volumn 9, Issue 1, 2013, Pages 80-92

  Yilmaz, Sema ^a   Inandiklioglu, Nihal ^b   Yildizdas, Dincer ^b   Subasi, Cansu ^c   Acikalin, Arbil ^b   Kuyucu, Yurdun ^b   Bayram, Ibrahim ^b   Topak, Ali ^b   Tanyeli, Atila ^b   Duruksu, Gokhan ^c   Karaoz, Erdal ^c  

^a ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c KOCAELI UNIVERSITY   (Turkey)

Author keywords

Acute respiratory distress syndrome; Critically ill; Cytokine; Inflammation; Mesenchymal stem cell

Indexed keywords

ANIMALIA; RATTUS;

EID: 84873744243     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-012-9395-2     Document Type: Article

References (37)

1. Ware, L. B., & Matthay, M. A. (2000). The acute respiratory distress syndrome. The New England Journal of Medicine, 342(18), 1334-1349.
2. Bernard, G. R., Artigas, A., Brigham, K. L., et al. (1994). Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee. Intensi{dotless}ve Care Medicine, 20(3), 225-232.
3. Tomashefski, J. F., Jr. (2000). Pulmonary pathology of acute respiratory distress syndrome. Clinics in Chest Medicine, 21(3), 435-466.
4. Matthay, M. A., & Zemans, R. L. (2011). The acute respiratory distress syndrome: pathogenesis and treatment. Annual Review of Pathology, 6, 147-163.
5. Dushianthan, A., Grocott, M. P., Postle, A. D., & Cusack, R. (2011). Acute respiratory distress syndrome and acute lung injury. Postgraduate Medical Journal, 87(1031), 612-622.
6. Calfee, C. S., & Matthay, M. A. (2007). Nonventilatory treatments for acute lung injury and ARDS. Chest, 131(3), 913-920.
7. Cepkova, M., & Matthay, M. A. (2006). Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. Journal of Intensive Care Medicine, 21(3), 119-143.
8. Rojas, M., Xu, J., Woods, C. R., et al. (2005). Bone marrow-derived mesenchymal stem cells in repair of the injured lung. American Journal of Respiratory Cell and Molecular Biology, 33(2), 145-152.
9. Dominici, M., Le Blanc, K., Mueller, I., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy, 8(4), 315-317.
10. Ortiz, L. A., Gambelli, F., McBride, C., et al. (2003). Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proceedings of the National Academy of Sciences, 100, 8407-8411.
11. Patel, S. A., Sherman, L., Munoz, J., & Rameshwar, P. (2008). Immunological properties of mesenchymal stem cells and clinical implications. Archivum Immunologiae et Therapiae Experimentalis, 56(1), 1-8.
12. Germann, P. G., & Häfner, D. (1998). A rat model of acute respiratory distress syndrome (ARDS): part 1. Time dependency of histological and pathological changes. Journal of Pharmacological and Toxicological Methods, 40(2), 101-107.
13. Häfner, D., & Germann, P. G. (1999). A rat model of acute respiratory distress syndrome (ARDS) part 2, influence of lavage volume, lavage repetition, and therapeutic treatment with rSP-C surfactant. Journal of Pharmacological and Toxicological Methods, 41(2-3), 97-106.
14. Gupta, N., Su, X., Popov, B., Lee, J. W., Serikov, V., & Matthay, M. A. (2007). Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. Journal of Immunology, 179(3), 1855-1863.
15. Lee, J. W., Gupta, N., Serikov, V., & Matthay, M. A. (2009). Potential application of mesenchymal stem cells in acute lung injury. Expert Opinion on Biological Therapy, 9(10), 1259-1270.
16. Sinclair, D. G., Braude, S., Haslam, P. L., & Evans, T. W. (1994). Pulmonary endothelial permeability in patients with severe lung injury. Clinical correlates and natural history. Chest, 106(2), 535-539.
17. Xu, J., Qu, J., Cao, L., et al. (2008). Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. The Journal of Pathology, 214, 472-481.
18. Lee, J. W., Fang, X., Gupta, N., Serikov, V., & Matthay, M. A. (2009). Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proceedings of the National Academy of Sciences, 106(38), 16357-16362.
19. Fang, X., Neyrinck, A. P., Matthay, M. A., & Lee, J. W. (2010). Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1. Journal of Biological Chemistry, 285(34), 26211-26222.
20. Stewart, D. J., & Mei, S. H. (2011). Cell-based therapies for lung vascular diseases: lessons for the future. Proceedings of the American Thoracic Society, 8(6), 535-540.
21. Aggarwal, S., & Pittenger, M. F. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 105(4), 1815-1822.
22. Corcione, A., Benvenuto, F., Ferretti, E., et al. (2006). Human mesenchymal stem cells modulate B-cell functions. Blood, 107(1), 367-372.
23. Bouffi, C., Bony, C., Courties, G., Jorgensen, C., & Noël, D. (2010). IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis. PLoS One, 5(12), e14247.
24. Lee, J. W., Fang, X., Krasnodembskaya, A., Howard, J. P., & Matthay, M. A. (2011). Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Stem Cells, 29(6), 913-919.
25. Takaoka, Y., Niwa, S., & Nagai, H. (1999). Interleukin-1beta induces interleukin-6 production through the production of prostaglandin E (2) in human osteoblasts, MG-63 cells. Journal of Biochemistry, 126(3), 553-558.
26. Geiser, T., Atabai, K., Jarreau, P. H., Ware, L. B., Pugin, J., & Matthay, M. A. (2001). Pulmonary edema fluid from patients with acute lung injury augments in vitro alveolar epithelial repair by an il-1beta-dependent mechanism. American Journal of Respiratory and Critical Care Medicine, 163(6), 1384-1388.
27. Chimenti, L., Luque, T., Bonsignore, M. R., Ramírez, J., Navajas, D., & Farré, R. (2012). Pre-treatment with mesenchymal stem cells reduces ventilator-induced lung injury. European Respiratory Journal. doi: 10. 1183/09031936. 00153211.
28. Raffaghello, L., Bianchi, G., Bertolotto, M., et al. (2008). Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells, 26, 151-162.
29. Tai, W. L., Dong, Z. X., Zhang, D. D., & Wang, D. H. (2012). Therapeutic effect of intravenous bone marrow-derived mesenchymal stem cell transplantation on early-stage LPS-induced acute lung injury in mice. Nan Fang Yi Ke Da Xue Xue Bao, 32(3), 283-290.
30. Nemeth, K., Leelahavanichkul, A., Yuen, P. S., et al. (2009). Bone marrow stromal cells attenuate sepsis via prostaglandin E (2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nature Medicine, 15(1), 42-49.
31. Volarevic, V., Al-Qahtani, A., Arsenijevic, N., Pajovic, S., & Lukic, M. L. (2010). Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis. Autoimmunity, 43(4), 255-263.
32. Ortiz, L. A., Dutreil, M., Fattman, C., et al. (2007). Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proceedings of the National Academy of Sciences, 104(26), 11002-11007.
33. Kleiveland, C. R., Kassem, M., & Lea, T. (2008). Human mesenchymal stem cell proliferation is regulated by PGE2 through differential activation of cAMP-dependent protein kinase isoforms. Experimental Cell Research, 314(8), 1831-1838.
34. Bunnell, B. A., Betancourt, A. M., & Sullivan, D. E. (2010). New concepts on the immune modulation mediated by mesenchymal stem cells. Stem Cell Research and Therapy, 1(5), 34.
35. Wu, L., Wang, Q., Liang, X., & Andreasson, K. (2007). Divergent effects of prostaglandin receptor signaling on neuronal survival. Neuroscience Letters, 421(3), 253-258.
36. Moore, B. B., Ballinger, M. N., White, E. S., et al. (2005). Bleomycin-induced E prostanoid receptor changes alter fibroblast responses to prostaglandin E2. Journal of Immunology, 174(9), 5644-5649.
37. Barbash, I. M., Chouraqui, P., Baron, J., et al. (2003). Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation, 108(7), 863-868.